Kevin Kee-Jong Hong
Company: Gachon University School of Medicine, Korea mRNA Vaccine Initiative (KmVAC)
Job title: Professor, Director General
Bio:
Kee-Jong Hong (BS, Seoul National Univ; MS, Seoul National Univ; PhD, Texas Tech Univ) is currently a Professor at the Department of the Microbiology, Gachon University School of Medicine, Korea, and a Program Manager of Division for Health Security at Korea Advanced Research Project Agency for Health (ARPA-H) after finishing Korean National project for the mRNA Vaccine R&D, KmVAC(Korea mRNA Vaccine Initiative). He has conducted research and development related to the pandemic preparedness including Influenza, Coronavirus, Ebola virus, Nipah virus and Bioterrorism pathogens such as Anthrax, tularemia. He worked for the Korean Dsease Control and Prevention Agency (KCDA) for 10 years as a government officer, also worked as a director of the industrial research institutes including the Interpark BioConvergence (currently Gradient BioConvergence) and the NKmax for another 7 years before joining the Gachon University. He is serving for the Korean Vaccine Society as a chair of publication committee, also serving for the Korean Society for Zoonoses as a vice president. In 2024, he was selected as a member of Scientific Advisory Committee for CEPI (Coalition for Epidemic Preparedness Innovations) and keeps working till 2027.
Seminars:
Establishing a Two-Track Strategy & Platform Technology Required for Next Pandemic Preparedness 9:00 am
Advancing decentralized manufacturing Developing extra long-term storage Combating pandemic preparednessRead more
day: Day Two
Panel Discussion – Fighting the Next Pandemic with mRNA Technology & Equitable Vaccine Supply Chain for Commercial Markets in Asia 11:15 am
With the Korean Disease Control and Prevention Agency’s mission to invest in the best mRNA technologies to fight the next pandemic, it’s more important than ever to establish collaborations between Korean and international partners to support regional and global health through establishment of local manufacturing of vaccine in LMICs Hear from vaccine experts as they…Read more
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One